Why should primary care physicians know about breast cancer genetics? (Q28383592)

Europe PubMed Central

title

Why should primary care physicians know about breast cancer genetics? (English)

0 references

E Levy-Lahad

4

0 references

author name string

L E Pinsky

1

0 references

J B Culver

2

0 references

J Hull

3

0 references

M Daly

5

0 references

W Burke

Western Journal of Medicine

6

0 references

language of work or name

English

0 references

publication date

September 2001

0 references

published in

0 references

volume

175

0 references

issue

3

0 references

page(s)

168-73

0 references

cites work

Frequency and carrier risk associated with common BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1071532

Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1071532

The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1071532

Women's perception of risk of cancer.

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1071532

Using gene carrier probability to select high risk families for identifying germline mutations in breast cancer susceptibility genes

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1071532

Determining carrier probabilities for breast cancer-susceptibility genes BRCA1 and BRCA2

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1071532

The lifetime risk of developing breast cancer

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1071532

Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1071532

Genetic analysis of breast cancer in the cancer and steroid hormone study

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1071532

Genetic testing for susceptibility to adult-onset cancer. The process and content of informed consent

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1071532

Women's interest in genetic testing for breast cancer susceptibility may be based on unrealistic expectations.

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1071532

Screening for genetic risk of breast cancer.

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1071532

BRCA1 sequence analysis in women at high risk for susceptibility mutations. Risk factor analysis and implications for genetic testing.

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1071532

Predisposition genetic testing for late-onset disorders in adults. A position paper of the National Society of Genetic Counselors.

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1071532

Probability of carrying a mutation of breast-ovarian cancer gene BRCA1 based on family history.

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1071532

Sequence analysis of BRCA1 and BRCA2: correlation of mutations with family history and ovarian cancer risk

27 November 2018

1 reference

12 December 2020

Population-based study of risk of breast cancer in carriers of BRCA2 mutation

1 reference

12 December 2020

A descriptive study of breast cancer worry

1 reference

12 December 2020

BRCA1 and BRCA2: a small part of the puzzle

1 reference

12 December 2020

A 40-year-old woman with a strong family history of breast cancer

1 reference

12 December 2020

Projecting individualized probabilities of developing breast cancer for white females who are being examined annually

1 reference

12 December 2020

Autosomal dominant inheritance of early-onset breast cancer. Implications for risk prediction

1 reference

12 December 2020

Assessment and counseling for women with a family history of breast cancer. A guide for clinicians

1 reference

12 December 2020

Women's receptivity to testing for a genetic susceptibility to breast cancer

1 reference

12 December 2020

Perceptions of breast cancer risk and screening effectiveness in women younger than 50 years of age

1 reference

12 December 2020

The effect of an educational intervention on the perceived risk of breast cancer

1 reference

12 December 2020

Genetic testing for breast cancer susceptibility: awareness and interest among women in the general population

1 reference

12 December 2020

BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer

1 reference

12 December 2020